These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28689588)

  • 1. Renal Manifestations of Hepatitis C Virus.
    Ferri C; Giuggioli D; Colaci M
    Clin Liver Dis; 2017 Aug; 21(3):487-497. PubMed ID: 28689588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrahepatic manifestations in chronic hepatitis C virus carriers.
    Rosenthal E; Cacoub P
    Lupus; 2015 Apr; 24(4-5):469-82. PubMed ID: 25801890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus associated glomerulopathies.
    Ozkok A; Yildiz A
    World J Gastroenterol; 2014 Jun; 20(24):7544-54. PubMed ID: 24976695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Extrahepatic Manifestations of Hepatitis C Virus.
    Degasperi E; Aghemo A; Colombo M
    Clin Liver Dis; 2017 Aug; 21(3):631-643. PubMed ID: 28689598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatologic manifestations of Hepatitis C Virus.
    Treppo E; Quartuccio L; Ragab G; DE Vita S
    Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
    Garini G; Allegri L; Lannuzzella F; Vaglio A; Buzio C
    Acta Biomed; 2007; 78(1):51-9. PubMed ID: 17687818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kidney involvement in mixed cryoglobulinemia: which treatment?].
    Cacoub P
    Presse Med; 2012 Mar; 41(3 Pt 1):254-9. PubMed ID: 22192935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consequences of extrahepatic manifestations of hepatitis C viral infection (HCV)].
    Pawełczyk A
    Postepy Hig Med Dosw (Online); 2016 Apr; 70():349-59. PubMed ID: 27117111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatologic Manifestations of Hepatitis C Virus Infection.
    Cacoub P; Comarmond C; Desbois AC; Saadoun D
    Clin Liver Dis; 2017 Aug; 21(3):455-464. PubMed ID: 28689585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
    Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
    Lunel F; Cacoub P
    Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrahepatic manifestations of HCV where do we stand?
    Mokhles MA
    Med Clin (Barc); 2024 Mar; 162(5):231-237. PubMed ID: 37980213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection and glomerular disease.
    Fabrizi F; Donato F; Messa P
    Minerva Urol Nefrol; 2014 Jun; 66(2):139-49. PubMed ID: 24988205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrahepatic morbidity and mortality of chronic hepatitis C.
    Negro F; Forton D; Craxì A; Sulkowski MS; Feld JJ; Manns MP
    Gastroenterology; 2015 Nov; 149(6):1345-60. PubMed ID: 26319013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.
    Roccatello D; Sciascia S; Rossi D; Solfietti L; Fenoglio R; Menegatti E; Baldovino S
    Oncotarget; 2017 Jun; 8(25):41764-41777. PubMed ID: 28454112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
    Cacoub P; Desbois AC; Isnard-Bagnis C; Rocatello D; Ferri C
    J Hepatol; 2016 Oct; 65(1 Suppl):S82-S94. PubMed ID: 27641990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
    Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
    Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection.
    Zignego AL; Gragnani L; Piluso A; Sebastiani M; Giuggioli D; Fallahi P; Antonelli A; Ferri C
    Expert Rev Clin Immunol; 2015 Jan; 11(1):15-31. PubMed ID: 25534977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.